Compound Family
SGLT2 Inhibitor dossiers
Sodium-glucose cotransporter blockers for diabetes and heart failure.
Showing 12 of 12 compounds
Molecular
View 3D Structure
SGLT2 Inhibitor
BEXAGLIFLOZIN
SGLT2 Inhibitor medication
TherapeuticClinical Research
Molecular
View 3D Structure
SGLT2 Inhibitor
Brenzavvy
SGLT2 Inhibitor medication (Bexagliflozin)
TherapeuticClinical Research
Molecular
View 3D Structure
SGLT2 Inhibitor
Canagliflozin
SGLT2 Inhibitor medication
TherapeuticClinical Research
Molecular
View 3D Structure
SGLT2 Inhibitor
Canagliflozin And Metformin Hydrochloride
SGLT2 Inhibitor medication (Metformin Hydrochloride; Canagliflozin)
TherapeuticClinical Research
Molecular
View 3D Structure
SGLT2 Inhibitor
Dapagliflozin
SGLT2 Inhibitor medication
TherapeuticClinical Research
Molecular
View 3D Structure
SGLT2 Inhibitor
Empagliflozin
SGLT2 Inhibitor medication
TherapeuticClinical Research
Molecular
View 3D Structure
SGLT2 Inhibitor
Ertugliflozin
SGLT2 Inhibitor medication
TherapeuticClinical Research
Molecular
View 3D Structure
SGLT2 Inhibitor
Farxiga
SGLT2 Inhibitor medication (Dapagliflozin)
TherapeuticClinical Research
Molecular
View 3D Structure
SGLT2 Inhibitor
Inpefa
SGLT2 Inhibitor medication (Sotagliflozin)
TherapeuticClinical Research
Molecular
View 3D Structure
SGLT2 Inhibitor
Invokana
SGLT2 Inhibitor medication (Canagliflozin)
TherapeuticClinical Research
Molecular
View 3D Structure
SGLT2 Inhibitor
Jardiance
SGLT2 Inhibitor medication (Empagliflozin)
TherapeuticClinical Research
Molecular
View 3D Structure
SGLT2 Inhibitor
Steglatro
SGLT2 Inhibitor medication (Ertugliflozin)
TherapeuticClinical Research